Compare BRKR & SF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRKR | SF |
|---|---|---|
| Founded | 1960 | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Bankers/Brokers/Service |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 12.7B |
| IPO Year | 2000 | N/A |
| Metric | BRKR | SF |
|---|---|---|
| Price | $34.28 | $71.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | $49.54 | ★ $89.17 |
| AVG Volume (30 Days) | ★ 2.0M | 1.3M |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | 0.59% | ★ 1.92% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,895,600,000.00 | N/A |
| Revenue This Year | $6.27 | $17.04 |
| Revenue Next Year | $3.78 | $7.61 |
| P/E Ratio | ★ N/A | $20.53 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.53 | $69.31 |
| 52 Week High | $56.22 | $134.74 |
| Indicator | BRKR | SF |
|---|---|---|
| Relative Strength Index (RSI) | 38.38 | 27.48 |
| Support Level | $29.54 | $69.31 |
| Resistance Level | $35.15 | $74.07 |
| Average True Range (ATR) | 1.64 | 1.73 |
| MACD | 0.26 | 1.93 |
| Stochastic Oscillator | 37.25 | 53.76 |
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Stifel Financial is a diversified financial-services provider that generates revenue from wealth management, investment banking, and lending. The firm was founded in 1890 as a St. Louis-based full-service brokerage but has been transformed under CEO Ronald Kruszewski through a slew of acquisitions into a globally competitive wealth manager, investment bank, and retail and institutional brokerage. The firm generated $5.5 billion in revenue in 2025, with roughly two-thirds derived from wealth management and one-third derived from investment banking and trading.